Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to determine whether a fixed-dose combination of naratriptan 2,5 mg + naproxen 500 mg is effective and safe compared each monotherapy for the acute treatment of migraine.
Epistemonikos ID: b13f8e3b2293c1a8ee08a99d564a57aa20fb7e37
First added on: May 11, 2024